PT-2006-6094 · Oracle · Oracle Pharmaceutical Applications

Published 2006-10-18 · Updated 2018-10-17 · CVE-2006-5374

Positive Technologies (AI Summary)

CVSS v2.0

10

High

Base vector

AV:N/AC:L/Au:N/C:C/I:C/A:C

Name of the Vulnerable Software and Affected Versions Oracle Pharmaceutical Applications version 4.5.1

Description The issue concerns an unspecified vulnerability with remote authenticated attack vectors. The impact of this issue is unknown.

Recommendations For Oracle Pharmaceutical Applications version 4.5.1, at the moment, there is no information about a newer version that contains a fix for this vulnerability.

Related Identifiers

CVE-2006-5374

Affected Products

Oracle Pharmaceutical Applications

References · 9

• http://securityfocus.com/archive/1/449711/100/0/threaded · Vendor Advisory
• http://securityfocus.com/bid/20588 · Patch
• https://nvd.nist.gov/vuln/detail/CVE-2006-5374 · Security Note
• http://secunia.com/advisories/22396 · Note
• http://vupen.com/english/advisories/2006/4065 · Note
• http://us-cert.gov/cas/techalerts/TA06-291A.html · Note
• http://securitytracker.com/id?1017077 · Note
• http://red-database-security.com/advisory/oracle_cpu_oct_2006.html · Note
• http://oracle.com/technetwork/topics/security/cpuoct2006-095368.html · Note